Large Molecule Bioanalytical Testing Services Global Market Report 2026-2035 | Identify High-Growth Opportunities and Develop Informed Commercial Strategies
The global large molecule bioanalytical testing services market is projected to grow from USD 3.11 billion in 2026 to USD 5.88 billion by 2035, with a CAGR of 7.3%. Growth is driven by increasing biologics pipelines, demand for personalized therapies, and outsourcing to CROs and CDMOs. Pharmacokinetics testing dominates at 45% of market revenue, while bioequivalence testing is expected to grow fastest. North America leads with 50% of global revenue, while Asia-Pacific is the fastest-growing region at 8.6% CAGR.